Literature DB >> 9435229

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).

M G Achen1, M Jeltsch, E Kukk, T Mäkinen, A Vitali, A F Wilks, K Alitalo, S A Stacker.   

Abstract

We have identified a member of the VEGF family by computer-based homology searching and have designated it VEGF-D. VEGF-D is most closely related to VEGF-C by virtue of the presence of N- and C-terminal extensions that are not found in other VEGF family members. In adult human tissues, VEGF-D mRNA is most abundant in heart, lung, skeletal muscle, colon, and small intestine. Analyses of VEGF-D receptor specificity revealed that VEGF-D is a ligand for both VEGF receptors (VEGFRs) VEGFR-2 (Flk1) and VEGFR-3 (Flt4) and can activate these receptors. However. VEGF-D does not bind to VEGFR-1. Expression of a truncated derivative of VEGF-D demonstrated that the receptor-binding capacities reside in the portion of the molecule that is most closely related in primary structure to other VEGF family members and that corresponds to the mature form of VEGF-C. In addition, VEGF-D is a mitogen for endothelial cells. The structural and functional similarities between VEGF-D and VEGF-C define a subfamily of the VEGFs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9435229      PMCID: PMC18457          DOI: 10.1073/pnas.95.2.548

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Proteolytic processing regulates receptor specificity and activity of VEGF-C.

Authors:  V Joukov; T Sorsa; V Kumar; M Jeltsch; L Claesson-Welsh; Y Cao; O Saksela; N Kalkkinen; K Alitalo
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

Review 2.  Mechanisms of angiogenesis.

Authors:  W Risau
Journal:  Nature       Date:  1997-04-17       Impact factor: 49.962

3.  Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family.

Authors:  M Orlandini; L Marconcini; R Ferruzzi; S Oliviero
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

5.  The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression.

Authors:  G Lennon; C Auffray; M Polymeropoulos; M B Soares
Journal:  Genomics       Date:  1996-04-01       Impact factor: 5.736

6.  Molecular cloning of cDNA for murine interleukin-3.

Authors:  M C Fung; A J Hapel; S Ymer; D R Cohen; R M Johnson; H D Campbell; I G Young
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

7.  Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.

Authors:  M Jeltsch; A Kaipainen; V Joukov; X Meng; M Lakso; H Rauvala; M Swartz; D Fukumura; R K Jain; K Alitalo
Journal:  Science       Date:  1997-05-30       Impact factor: 47.728

8.  AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor.

Authors:  K Weindel; D Marmé; H A Weich
Journal:  Biochem Biophys Res Commun       Date:  1992-03-31       Impact factor: 3.575

9.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

10.  VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.

Authors:  E Kukk; A Lymboussaki; S Taira; A Kaipainen; M Jeltsch; V Joukov; K Alitalo
Journal:  Development       Date:  1996-12       Impact factor: 6.868

View more
  265 in total

Review 1.  Effect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C.

Authors:  K Narko; B Enholm; T Mäkinen; A Ristimäki
Journal:  Int J Exp Pathol       Date:  1999-06       Impact factor: 1.925

2.  Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.

Authors:  Rizwan Masood; Ethel Cesarman; D Lynne Smith; Parkash S Gill; Ornella Flore
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 3.  Angiogenesis in hematologic malignancies and its clinical implications.

Authors:  Renchi Yang; Zhong Chao Han
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

4.  Molecular characterization of lymphatic endothelial cells.

Authors:  Simona Podgrabinska; Pascal Braun; Paula Velasco; Bryan Kloos; Michael S Pepper; Mihaela Skobe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-22       Impact factor: 11.205

5.  Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life span.

Authors:  Riccardo E Nisato; Jillian A Harrison; Raphaele Buser; Lelio Orci; Chris Rinsch; Roberto Montesano; Philippe Dupraz; Michael S Pepper
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

Review 6.  Targeting non-malignant disorders with tyrosine kinase inhibitors.

Authors:  Friedrich Grimminger; Ralph T Schermuly; Hossein A Ghofrani
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

Review 7.  Current views on the function of the lymphatic vasculature in health and disease.

Authors:  Yingdi Wang; Guillermo Oliver
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

8.  NFATc1 regulates lymphatic endothelial development.

Authors:  Rishikesh M Kulkarni; James M Greenberg; Ann L Akeson
Journal:  Mech Dev       Date:  2009-02-20       Impact factor: 1.882

9.  Vascular endothelial growth factor D is dispensable for development of the lymphatic system.

Authors:  Megan E Baldwin; Michael M Halford; Sally Roufail; Richard A Williams; Margaret L Hibbs; Dianne Grail; Hajime Kubo; Steven A Stacker; Marc G Achen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 10.  Novel molecular pathways in Gorham disease: implications for treatment.

Authors:  Jeroen Hagendoorn; Torunn I Yock; Inne H M Borel Rinkes; Timothy P Padera; David H Ebb
Journal:  Pediatr Blood Cancer       Date:  2013-11-08       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.